Back to Search
RAVI SANTHANAM, MD
MD
Internal Medicine Physician
NPI: 1598856304IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
M0898(TX)
Hospitalist Physician
Hospitalist
Code: 208M00000X
M0898(TX)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1991
Research & Publications (19)
Fatal intratumoral hemorrhage in posterior fossa tumors following ventriculoperitoneal shunt.
PMID 19013806·J Clin Neurosci·2009
5-case
Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.
PMID 19411629·Blood·2009
7-preclinical
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
PMID 17761520·Blood·2008
7-preclinical
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.
PMID 17925491·Blood·2008
7-preclinical
Is it trichotillomania? Hair pulling in childhood: a developmental perspective.
PMID 18783123·Clin Child Psychol Psychiatry·2008
4-observational
Multiple myeloma and hypercoagulability leading to internal jugular vein thrombosis in a dialysis patient.
PMID 17257353·Hemodial Int·2007
5-case
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
PMID 17475908·Blood·2007
7-preclinical
Dealing with suicidal thoughts in schools: information and education directed at secondary schools.
PMID 18027138·Australas Psychiatry·2007
8-other
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.
PMID 17875674·J Exp Med·2007
7-preclinical
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
PMID 17717597·J Clin Invest·2007
7-preclinical
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
PMID 17671235·Blood·2007
3-trial
Genetic modification of cerebral arterial wall: implications for prevention and treatment of cerebral vasospasm.
PMID 17164039·Neurol Res·2006
6-review
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation.
PMID 16293596·Blood·2006
8-other
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.
PMID 16286244·Cancer Cell·2005
7-preclinical
Adapting the 'family wellbeing' empowerment program to the needs of remote indigenous school children.
PMID 15915613·Aust N Z J Public Health·2005
8-other
Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
PMID 12372395·Biochem Biophys Res Commun·2002
7-preclinical
Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model.
PMID 12052239·Reproduction·2002
7-preclinical
Novel human testis-specific cDNA: molecular cloning, expression and immunobiological effects of the recombinant protein.
PMID 11550262·Mol Reprod Dev·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21 SPURS LN, SUITE 230B
SAN ANTONIO, TX 78240 - Phone
- (210) 690-7400
Quick Facts
- NPI
- 1598856304
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 19
Are you this provider?
Claim Your Profile